Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Arthritis and Rheumatism|August 12, 2003
Physical function and health-related quality of life of Spanish patients with ankylosing spondylitisRafael Ariza-Ariza, Blanca Hernández-Cruz, Federico Navarro-SarabiaReumatologia Clinica|November 15, 2011
[Vaccines and chemo-prophylaxis in rhemautoid arthritis: is a vaccine calendar necessary?]Belén Carmen Garrido López, María Victoria Navarro Compain, Federico Navarro SarabiaThe Journal of Rheumatology|May 3, 2006
Adalimumab for treating rheumatoid arthritisFederico Navarro-Sarabia, Rafael Ariza-Ariza, Blanca Hernández-Cruz, et al.Clinical Rheumatology|October 1, 2008
Variables related to utility in patients with ankylosing spondylitisRafael Ariza-Ariza, Blanca Hernández-Cruz, Gloria López-Antequera, et al.Arthritis Research & Therapy|November 9, 2016
Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritisBlanca Hernández-Cruz, Esther Márquez-Saavedra, Rafael Caliz-Caliz, et al.Reumatologia Clinica|July 29, 2011
[A bibliometric approach to research into fibromyalgia]Luis Antonio Merayo Alonso, Francisco Javier Cano García, Luis Rodríguez Franco, et al.Rheumatology International|June 25, 2013
A comparison of telephone and paper self-completed questionnaires of main patient-related outcome measures in patients with ankylosing spondylitis and psoriatic arthritisRafael Ariza-Ariza, Blanca Hernández-Cruz, Victoria Navarro-Compán, et al.Arthritis and Rheumatism|October 3, 2006
Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQolRafael Ariza-Ariza, Blanca Hernández-Cruz, Loreto Carmona, et al.Clinical Rheumatology|March 5, 2011
Low doses of etanercept can be effective in ankylosing spondylitis patients who achieve remission of the diseaseVictoria Navarro-Compán, Virginia Moreira, Rafael Ariza-Ariza, et al.Reumatologia Clinica|June 15, 2016
Association between serum dickkopf-1 levels and disease duration in axial spondyloarthritisRoxana Rubio Vargas, Enrique Melguizo Madrid, Concepción González Rodríguez, et al.Pageof 3